Abstract
The antianxiety drug buspirone is favored for anxious patients with Alzheimer's disease (AD) because it is less sedating that the benzodiazepine tranquilizers, which may worsen cognitive impairment. But how safe is buspirone for AD patients? A review of medical research finds several prominent similarities between AD pathology and buspirone pharmacology, raising concerns that buspirone could significantly augment cognitive decline in AD.
Get full access to this article
View all access options for this article.